The user facility reported to terumo cardiovascular that during pre cardiopulmonary bypass, the oxygenator clotted.It is unknown whether the product was changed out, or if there was any effect on the patient or results of the surgery.Terumo continues to attempt to gain more information regarding this event from the user facility.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on april 10, 2020.Upon further investigation of the reported event, the following information is new and/or changed: g4 (date received by manufacturer) g7 (indication that this is a follow-up report) h2 (follow-up due to additional information) h6 (identification of evaluation codes 4114, 3221, 4315).Method code: 4114 - device not returned.Results code: 3221 - no findings available conclusions code: 4315 - cause not established.The actual sample was not returned for evaluation and the lot number was not provided; therefore, a thorough investigation could not be performed and a definitive root cause could not be determined.Review of past complaint records, confirmed no other similar complaint for the same product code.All available information has been placed on file in quality management for appropriate tracking, trending and follow-up.
|